Last $0.0048 USD
Change Today 0.00 / 0.00%
Volume 58.9K
POSC On Other Exchanges
As of 8:10 PM 07/9/14 All times are local (Market data is delayed by at least 15 minutes).

positron corp (POSC) Snapshot

Previous Close
Day High
Day Low
52 Week High
01/31/14 - $0.01
52 Week Low
09/3/13 - $0.0025
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for POSITRON CORP (POSC)

Related News

No related news articles were found.

positron corp (POSC) Related Businessweek News

No Related Businessweek News Found

positron corp (POSC) Details

Positron Corporation, a nuclear medicine healthcare company, provides positron emission tomography (PET) molecular imaging systems, clinical and support services, automated radiopharmaceutical systems, radiopharmaceuticals, and radioisotope processing and production services. Its products and services enable healthcare providers to diagnose disease and enhance patient outcomes. The company operates in two segments, Medical Equipment and Radiopharmaceuticals. Its products include Attrius, a PET scanner for cardiac imaging; and PosiStar that provides clinical and service support, uptime guarantees, remote access diagnostic/maintenance, physician interpretation training, billing training, nurse training, post-install physician over-reads, ICANL approval assistance, six months evaluation/assessment, industry luminary collaboration, etc. The company also produces PosiRx, a radiopharmaceutical system that automates the elution, preparation, and dispensing processes for radiopharmaceutical agents used in molecular imaging; and radioisotopes comprising API grade strontium-82. Positron Corporation was founded in 1983 and is based in Westmont, Illinois.

22 Employees
Last Reported Date: 03/31/14
Founded in 1983

positron corp (POSC) Top Compensated Officers

Chairman and Chief Executive Officer
Total Annual Compensation: $150.0K
President and Director
Total Annual Compensation: $156.0K
Chief Financial Officer, Executive Vice Presi...
Total Annual Compensation: $150.0K
Executive Director of Radioisotopes
Total Annual Compensation: $148.0K
Executive Director of Sales & Marketing
Total Annual Compensation: $147.0K
Compensation as of Fiscal Year 2013.

positron corp (POSC) Key Developments

Positron Corporation Appoints Joseph G. Oliverio as President

Positron Corporation announced the appointment of Joseph G. Oliverio as its President. Mr. Oliverio will direct the Company's cardiac PET mission and oversee Positron's PET technology, radiopharmaceutical partnerships, clinical and technical applications for new customer sales and exiting users. Joseph Oliverio has been a member of Positron's Board of Directors since 2006 and has served as its President, Chief Technical Officer and Executive Director of PET during that time. Mr. Oliverio has been instrumental in guiding the development and introduction of Positron's cardiac PET technology and has provided the vision of its molecular imaging strategy since joining the Company. Mr. Oliverio was a pioneer as Chief Operating Officer for the first freestanding heart disease reversal and prevention clinic guided by PET, and the first community based hospital offering cardiac PET in the emergency room setting, combined with an innovative heart disease reversal program.

Positron Corporation announced delayed 10-Q filing

On 05/15/2013, Positron Corporation announced that they will be unable to file their next 10-Q by the deadline required by the SEC.

Positron Corporation and Biologics Modular, LLC Enter into Co-Marketing Agreement

Positron Corporation announced a co-marketing agreement with Biologics Modular. Biologics Modular designs and manufacturers modular facilities that serve as self-contained biorepositories, biomanufacturing suites and research suites. PosiRx provides its users the ability to create patient specific unit doses in an ISO Class 5 environment and aids in compliance with USP 797 regulations. For those customers that need additional cleanroom capacity, such as pharmacies providing custom compounding of cancer treatment therapies, Biologics Modular has the most comprehensive and cost effective solution on the market. By decreasing start-up time and reducing operational costs, the combined solution allows new markets to be serviced sooner, and more profitably, than previously possible.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
POSC:US $0.00 USD 0.00

POSC Competitors

Market data is delayed at least 15 minutes.

Company Last Change
General Electric Co $26.32 USD -0.05
Koninklijke Philips NV €23.71 EUR +0.275
Pointer Telocation Ltd $8.65 USD +0.12
View Industry Companies

Industry Analysis


Industry Average

Valuation POSC Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 4.1x
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales 6.0x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact POSITRON CORP, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at